Kheiron Medical Technologies utilises deep learning to revolutionise cancer diagnostics, merging AI with human expertise. With a mission to enhance early cancer detection, their solutions empower radiologists, significantly improving accuracy and efficiency. Founded by Peter Kecskemethy and Tobias Rijken in 2016, Kheiron combines AI with clinical insight, aiming for better patient outcomes. Notably, their collaborations with NHS Grampian and Gateshead Health Foundation NHS Trust highlight real-world impact. Certified for security and quality, they maintain rigorous standards, backed by investors like Atomico.